The Lorazepam Tablets, cataloged under National Stock Number 6505-01-365-2072, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Bausch Health Us Llc. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-365-2072 |
| Primary Part Number | NDC00187-0063-01 |
| Item Name | Lorazepam Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Bausch Health Us Llc |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Protective Storage Feature | SECURITY STORAGE |
| Active Medicament Medicinal Strength | 0.500 MILLIGRAMS LORAZEPAM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00187-0063-01 PRIMARY | Bausch Health Us Llc (USA) |
| NDC69315-0904-01 PRIMARY | Leading Pharma Llc (USA) |
| NDC00904-6007-60 | The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories (USA) |
| Reference | Meaning |
|---|---|
| A92H282 | 5/1 Secondary reference Department of the Army U S Army Medical Material Agency Mcmr-Mmo-Sa |
NSN 6505-01-365-2072 is a Lorazepam Tablets, manufactured by Bausch Health Us Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-365-2072 has 3 manufacturer part numbers on file: NDC00187-0063-01 (Bausch Health Us Llc), NDC69315-0904-01 (Leading Pharma Llc), NDC00904-6007-60 (The Harvard Drug Group, L.l.c. Dba the Harvard Drug Group, L.l.c Div Major Pharmaceuticals & Rugby Laboratories).
Key specifications for NDC00187-0063-01: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Protective Storage Feature: SECURITY STORAGE. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.